The SiroSkin study: A multi-centre randomised double-blind placebo-controlled trial of 1% topical sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ... (Stream 7) (2022–2027)

Grant type:
NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
Researchers:
  • St Baker Soyer Chair of Dermatology
    Frazer Institute
    Faculty of Medicine
  • Mayne Chair and Head of Mayne
    Medical School (Office & AME)
    Faculty of Medicine
    Professor in Thoracic Med (Second)
    Prince Charles Hospital Northside Clinical Unit
    Faculty of Medicine
  • Associate Professor Dermatology
    Frazer Institute
    Faculty of Medicine
    Course Coordinator
    General Practice Clinical Unit
    Faculty of Medicine
Funded by:
Commonwealth Department of Health and Aged Care